Navigation Links
Verenium Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2010
Date:3/1/2011

on
  • SG&A: $23 to $25 million

  • Planned capital investments for the commercial business, including manufacturing debottlenecking, are expected to be between $4 and $6 million.  In addition, the Company expects to spend up to $10 million to build out a new San Diego, CA facility over the next two years and is exploring opportunities for spreading the capital expenditure over a longer period of time.

    About VereniumVerenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com.

    Forward-Looking StatementsStatements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's lines of business, operations, capabilities, commercialization activities, corporate partnerships, target markets and future financial performance, results and objectives, all of which are prospective.  Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements.  Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's strategic focus, risks associated with Verenium's technologies, risks associated with Verenium's ability to obtain additional capital to support its planned operations and financial obligations, risks associated with Verenium's dependence on patents and proprietary rights, risks associated with Verenium's protection and enforcement of its patents and proprietary rights, the commercial prospects of the industries in which Verenium operate
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Verenium Announces 2010 Business Update and Outlook for 2011
    2. Verenium Announces Changes in Senior Management
    3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    4. Spherix Reports Second Quarter Earnings
    5. Tapestry Reports Second Quarter 2007 Results
    6. Callisto Reports on Second-Quarter 2007 Milestones
    7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
    8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
    9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
    11. Biopure Reports on Meeting with the FDA
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... PARK, N.C. , July 31, 2014 ... Miami facilities to meet the clinical trial ... .  The newly expanded facility will continue to ... consolidation of shipments to and from the region, and ... its newest location, Marken will combine its office and ...
    (Date:7/31/2014)... juli 2014 De Pfizer Clinical Research Unit ... gezonde vrijwilligers van Japanse komaf voor medewerking aan klinisch ... PCRU is één van twee onderzoekseenheden van Pfizer ... te verbeteren door de ontdekking en ontwikkeling van nieuwe ... zoek naar mannen en vrouwen van Japanse komaf – ...
    (Date:7/30/2014)... SUNNYVALE, Calif. , July 30, 2014 /PRNewswire/ ... that its group purchasing contract with Premier will ... through the Premier GPO will be able to ... including Amerinet, Baycare, HPA, MedAssets, Novation, and ROi, ... HealthTrust, or directly with Cepheid. "Cepheid ...
    Breaking Medicine Technology:Marken Expands Miami Regional Logistics Center 2Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3
    ... Mass., May 9, 2011 CardioFocus, Inc., developer of ... of Atrial Fibrillation (AF), announced its technology enables a ... with approximately 86% of PVs remaining persistently isolated after ... patients achieve durable freedom from AF after a single ...
    ... 2011 Reportlinker.com announces that a new market research ... Brazil Biomaterial Market (2010 – 2015) ... The Brazil market for biomaterials is expected ... in 2008 with a CAGR of 19.5% from 2010 ...
    Cached Medicine Technology:New Studies Support CardioFocus HeartLight™ Endoscopic Ablation System's Notable Treatment Results for Paroxysmal Atrial Fibrillation 2New Studies Support CardioFocus HeartLight™ Endoscopic Ablation System's Notable Treatment Results for Paroxysmal Atrial Fibrillation 3Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 2Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 3Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 4Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 5Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 6Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 7Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 8Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 9Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 10Reportlinker Adds Brazil Biomaterial Market (2010 - 2015) 11
    (Date:7/31/2014)... Quincy Bioscience, a fast-growing biotech company in ... releases the second edition of the Making Memories e-booklet ... Birth of a Grandchild. , The Prevagen-sponsored e-book ... and ideas for grandparents to utilize during the precious ... concept published in the e-book is free or low-cost ...
    (Date:7/31/2014)... (PRWEB) July 31, 2014 FORT ... Holdings Inc. a leading US Joint Commission Accredited ... most innovative and technologically advanced consumer storage and ... teleradiology leader is providing valued members the use ... the extraordinary services already offered by SecondOpinions.com®. ...
    (Date:7/31/2014)... During an annual summer didactic and live ... Dallas plastic surgeon and a member of the ... demonstration of facial anatomy and key advances in facial ... Summer Meeting of the Cosmetic Bootcamp included lectures, anatomical ... key principles in modern facial surgery. , One of ...
    (Date:7/31/2014)... July 31, 2014 Body Well Therapy ... insurance patients seeking massage therapy in all 44 states ... option for Licensed Massage Therapists who do not otherwise ... to BWT. Should a patient request a specific qualified ... can then contract the therapist to provide therapeutic massage ...
    (Date:7/31/2014)... July 31, 2014 Cheerag D. ... sub-specialty trained neurosurgeons at the Saint Luke’s Marion ... Program and director of spine surgery. He comes to ... , “Dr. Upadhyaya has been recognized for his excellent ... spine issues. His addition to the Saint Luke’s Marion ...
    Breaking Medicine News(10 mins):Health News:Quincy Bioscience Launches the Second E-Book of the Making Memories Series 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3Health News:Dr. Rod J. Rohrich Demonstrates Advances in Facial Surgery at Annual Cosmetic Surgery Seminar 2Health News:Dr. Rod J. Rohrich Demonstrates Advances in Facial Surgery at Annual Cosmetic Surgery Seminar 3Health News:Body Well Therapy Invites Massage Therapists Nationwide to "Bring Your Own Insurance Clients" 2Health News:Body Well Therapy Invites Massage Therapists Nationwide to "Bring Your Own Insurance Clients" 3Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 2Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 3Health News:Saint Luke’s Marion Bloch Neuroscience Institute welcomes Cheerag D. Upadhyaya, M.D., as director of Spine Program 4
    ... 25 Pharmavite, a leader in ... on-line consumer-centric,program, LearnSomethingAbout(TM), as a partner ... engaging, consumer-oriented multimedia,program that seamlessly integrates ... "LearnSomething shares similar goals with ...
    ... - New Member of the ACL TOP Family -, ... it has received FDA clearance 510(k) for the ACL,TOP software ... 500 CTS,Hemostasis Testing System in the United States as a ... same advanced technology as the other members of the ACL,TOP ...
    ... WESTFORD, Mass., June 25 Cynosure, Inc.,(Nasdaq: CYNO ... array of,light-based aesthetic treatment systems, today announced the opening ... China. Located in the Chao,Yang District of Beijing, the ... of sales and marketing for Cynosure China, the company,s,wholly ...
    ... Shows Nearly 90 Percent of Sponges and Half of Sinks ... Harbor High Levels of Illness-Causing Bacteria, PARSIPPANY, ... high levels of potentially dangerous bacteria, according to a,new international ... swabbing for bacteria in the United,States and around the world ...
    ... LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider of ... is providing an update on the company,s ... the company,s services., "Macro-economic conditions continue ... leading to continued softness in,LasikPlus(R) appointments by ...
    ... million of required financing now in place ... - Bioniche Life Sciences,Inc. (TSX: BNC), a ... it has secured an amendment,to a pre-existing ... Office of Industry Canada that will support ...
    Cached Medicine News:Health News:Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM) 2Health News:Instrumentation Laboratory Launches ACL Top(R) 500 CTS Hemostasis Testing System 2Health News:Cynosure Expands Presence in China with the Opening of Sales Office in Beijing 2Health News:Hidden Kitchen Germs Threaten Families 2Health News:Hidden Kitchen Germs Threaten Families 3Health News:Hidden Kitchen Germs Threaten Families 4Health News:Hidden Kitchen Germs Threaten Families 5Health News:Hidden Kitchen Germs Threaten Families 6Health News:Hidden Kitchen Germs Threaten Families 7Health News:LCA-Vision Provides Business Update and Market Review 2Health News:LCA-Vision Provides Business Update and Market Review 3Health News:LCA-Vision Provides Business Update and Market Review 4Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 2Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 3Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 4
    ... Streptavidin magnetic beads are ... covalently coupled to a ... substrates can be useful ... experiments including mRNA isolation ...
    ... The OptiMAL® assay is a ... assay that permits the detection ... human malaria; and can distinguish ... and P. vivax . ...
    For the detection of pan specific pLDH, utilizing whole blood samples. Parabank excludes infected blood from the blood supply in the blood bags....
    ... FalciVax is a two site ... for the detection of P. ... (Pf. HRP-2) and P. vivax ... also be used for specific ...
    Medicine Products: